Your browser doesn't support javascript.
loading
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
de Vries, Simone; Schaapveld, Michael; Janus, Cécile P M; Daniëls, Laurien A; Petersen, Eefke J; van der Maazen, Richard W M; Zijlstra, Josée M; Beijert, Max; Nijziel, Marten R; Verschueren, Karijn M S; Kremer, Leontien C M; van Eggermond, Anna M; Lugtenburg, Pieternella J; Krol, Augustinus D G; Roesink, Judith M; Plattel, Wouter J; van Spronsen, Dick Johan; van Imhoff, Gustaaf W; de Boer, Jan Paul; Aleman, Berthe M P; van Leeuwen, Flora E.
Afiliação
  • de Vries S; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Schaapveld M; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Janus CPM; Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
  • Daniëls LA; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Petersen EJ; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Maazen RWM; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Zijlstra JM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Beijert M; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Nijziel MR; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • Verschueren KMS; Department of Hematology, Catharina Hospital, Eindhoven, the Netherlands.
  • Kremer LCM; Department of Radiation Oncology, Institute Verbeeten, Tilburg, the Netherlands.
  • van Eggermond AM; Late Effects Research Group, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Lugtenburg PJ; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Krol ADG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Roesink JM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Plattel WJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Spronsen DJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • van Imhoff GW; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • de Boer JP; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Aleman BMP; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Leeuwen FE; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
J Natl Cancer Inst ; 113(6): 760-769, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33351090
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Segunda Neoplasia Primária Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Segunda Neoplasia Primária Idioma: En Ano de publicação: 2021 Tipo de documento: Article